CRTHF (CARsgen Therapeutics Holdings) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRTHF CARsgen Therapeutics Holdings Ltd CRTHF
21 GF Score
Price $2.16
! 3 Warning Signs
View Full Analysis

What is CARsgen Therapeutics Holdings Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

CRTHF
21GF Score
CARsgen Therapeutics Holdings Ltd CRTHF
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARsgen Therapeutics Holdings Business Description

Other Exchanges 02171:Hong Kong
Address No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
21GF Score

Get the complete analysis for CRTHF

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.16
Price